DoxyPEP: Using antibiotics to prevent STIs
Doxycycline post-exposure prophylaxis (doxyPEP) effectively prevents syphilis and chlamydia in gay, bisexual men, and trans women, with less efficacy against gonorrhoea. Concerns about antibiotic resistance persist. Research supports its use in high-risk groups, though evidence for cisgender women is lacking. Guidelines vary, with some advocating for its use while others caution due to resistance risks.
Reference News
Doxycycline post-exposure prophylaxis (doxyPEP) effectively prevents syphilis and chlamydia in gay, bisexual men, and trans women, with less efficacy against gonorrhoea. Concerns about antibiotic resistance persist. Research supports its use in high-risk groups, though evidence for cisgender women is lacking. Guidelines vary, with some advocating for its use while others caution due to resistance risks.